medicinal plants of ethiope west and sapele local government areas of delta state, nigeria

Clicks: 209
ID: 205834
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #16 of 28 articles by views in international journal of pharma and bio sciences

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract

Medicinal plants used by the Urhobo people of Ethiope West and Sapele local government areas of Delta State of Nigeria were documented. Fifty one plant species belonging to thirty one families are used for the treatment and management of diseases such as measles, diabetes, stroke, jaundice, malaria, typhoid, hypertension, gonorrhoea and rheumatism. The list provides useful information on medicinal plants and their uses. This may serve as a lead for further scientific studies aimed at ascertaining the veracity or otherwise the therapeutic claims ascribed to the plants by the indigenous people of the region. The need to conserve these medicinal plants in the region is hereby emphasized.

DOI: http://dx.doi.org/10.3126/ije.v3i3.11084

International Journal of Environment Vol.3(3) 2014: 252-263

Reference Key
fasola2014internationalmedicinal Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Taiye R Fasola;A Egunyomi;EO Odudu
Journal international journal of pharma and bio sciences
Year 2014
DOI
10.3126/ije.v3i3.11084
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.